Introduced February 14, 2020, Senate Bill 787 provides benefits to pharmacists for care rendered within the pharmacist's scope of practice if such benefits would ordinarily be paid if the service was performed by another health care provider. This is a new section of Chapter 33-53-1 -- referred [Read more...]
Senate Bill 689 requires drug manufacturers and health benefit plan issuers who sell prescription drugs in West Virginia to provide cost information, changes in cost information, and prescription drug statistics to the State Auditor. The bill requires the Auditor to publish this information on [Read more...]
Introduced February 7, House Bill 4739 promotes transparency in the operation of pharmacy services administrative organizations (PSAO) by establishing a licensure requirement and providing for the regulation of the same by the Insurance Commission. A PSAO pharmacy contract shall include a [Read more...]
House Bill 4543 calls for a cap on costs for insulin. It is estimated over 240,000 West Virginians are diagnosed and living with type 1 or type 2 diabetes and another 65,000 are undiagnosed. Every West Virginian with type 1 diabetes and many with type 2 diabetes rely on daily doses of insulin [Read more...]